Melatonin (saliva or urine)
Adrenal · specimen: saliva, urine
Also called: salivary melatonin, urinary melatonin, 6-sulfatoxymelatonin, dim light melatonin onset, DLMO
Chart note
ND-recommended test reviewed: melatonin (saliva or urine). Indications reviewed: insomnia, fatigue, circadian or adrenal imbalance; no validated primary-care indication for this test identified. Not ordered. Rationale discussed: melatonin level is not standardized for routine diagnosis and does not change management in primary care. Patient informed test available privately via ND. Patient given info page: https://labs.ajaxharwoodclinic.com/melatonin/patient Revisit if: symptoms suggest a specific sleep disorder warranting sleep-medicine referral.
Indicated when
None recorded.
Not indicated when
- Routine testing of a melatonin level to investigate fatigue, insomnia, or 'adrenal'/circadian imbalance in primary care: no guideline reviewed for this record recommends measuring melatonin for these indications
- Guiding melatonin supplement dosing from a single level
Why not
No guideline located in this batch sets a reference range or a primary-care diagnostic cutoff for a measured melatonin level, so an out-of-range result can't be reliably interpreted or acted on. Timing and light exposure strongly affect melatonin levels (standard physiology, not sourced in this batch; see evidence_notes).
Better first step
For suspected insomnia or disrupted sleep, assess with a sleep history and sleep diary, and refer to sleep medicine if a circadian rhythm or other sleep disorder is suspected, rather than ordering a melatonin level.
Typical ND rationale
An ND may order salivary or urinary melatonin to check whether a disrupted sleep-wake or circadian rhythm is contributing to fatigue or poor sleep, reasoning that a low or mistimed melatonin level explains the symptoms and can guide melatonin dosing.
Where the ND is right
No validated primary-care situation for ordering a melatonin level was identified; the underlying concern (poor sleep, fatigue) is worth assessing with a sleep history and, where indicated, formal sleep-medicine tools.
Ontario coverage & CONO orderability
- OHIP status
- unverified
- Melatonin is explicitly named as not found in the 2026 community Schedule of Benefits for Laboratory Services; absence from the Schedule is not proof it is never covered in any Ontario context, but no Ontario source establishing coverage was found this session. ND-ordered testing is patient-paid regardless [4, 5].
- CONO orderable
- Yes — CONO list #158, #180
- CONO list items 158 (urine) and 180 (saliva), both 'Melatonin.'
Linked conditions
Counselling script
“A melatonin level isn't something I can reliably act on in this setting — the result depends heavily on light exposure and timing, and there's no standard cutoff that would change what we'd do. Let's focus on your sleep history instead, and I can refer you to sleep medicine if needed.”
Revisit if
- Symptoms suggest a specific sleep or circadian rhythm disorder warranting sleep-medicine referral
References
- [1]Endocrine Society (2008). The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. linkolder guidelineMelatonin does not appear among the recommended diagnostic tests for Cushing's syndrome in this guideline
- [2]Endocrine Society (2016). Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. linkMelatonin does not appear among the recommended diagnostic tests for primary adrenal insufficiency in this guideline
- [3]Ontario Ministry of Health (2026). Ontario Health Insurance Plan: Schedule of Benefits for Laboratory Services (effective April 1, 2026). linkMelatonin is not a line item in the community lab Schedule of Benefits
- [4]Government of Ontario (e-Laws) (2026). Health Insurance Act, R.R.O. 1990, Reg. 552: General, s. 22 (insured laboratory services). linkA lab test is insured only when ordered by a physician, midwife, or NP who has clinically assessed the patient
- [5]Ontario Ministry of Health (2026). Ontario Health Insurance Plan: Schedule of Benefits for Laboratory Services (effective April 1, 2026). linkTests ordered by anyone other than an authorized provider, including NDs, are not insured services
Evidence notes
This session could not locate a sleep-medicine guideline directly validating (or rejecting) melatonin testing (for example, dim-light melatonin onset protocols) despite several PubMed searches; the strongest lead found (an AASM actigraphy guideline, PMID 29991437) addresses actigraphy, not melatonin assays, and was not cited here to avoid overstating its relevance. The general physiological claims in why_not (pulsatile secretion, light sensitivity) reflect standard, uncontroversial endocrine/sleep physiology rather than a specific fetched source, and are flagged here rather than backed by a reference entry. This is a genuine gap worth a dedicated pass before clinical sign-off, particularly to check whether a sleep-medicine body has published guidance on DLMO testing that a broader search would find.